Age-related macular degeneration is the leading cause of central vision loss in individuals over 50 in industrialized nations. Alarmingly, the number of affected patients is anticipated to triple over the next 25 years. This comprehensive, multi-authored volume offers an up-to-date exploration of this prevalent retinal disease, presenting the latest advancements in our understanding of its etiology, risk factors, diagnostics, and therapeutic strategies.
Within this expertly crafted book, readers will find detailed discussions on epidemiologically and genetically identified risk factors. The text delves into various pathophysiological aspects, including the crucial role of the complement system, and clearly outlines clinical manifestations, with a focus on OCT and angiographic characteristics.
Furthermore, the book presents and critically examines different therapeutic approaches, highlighting proven treatments such as intravitreal anti-VEGF therapy and vision-aid systems. It also introduces readers to the latest and most promising pharmacological methods.
This well-illustrated volume, complete with tables and summaries, is an essential resource for ophthalmologists, researchers, and medical professionals seeking a deeper understanding of age-related macular degeneration. Its clear presentation and comprehensive coverage make it a standout reference in the field.
Discover the knowledge advancements that can aid in combating this growing vision impairment issue, and equip yourself with the tools to make informed, impactful decisions in clinical practice.
Authors:
Frank G. Holz (Editor),
Edition:
2nd
Publication Date:
August 31, 2012
Reviews
There are no reviews yet.